



We read with great interest the article by Wakabayashi et al1 recently 
published in Circulation: Cardiovascular Interventions. Wakabayashi 
et al reviewed the mechanisms of edge restenosis, bringing insights 
into the possible underlying causes of this phenomenon analyzing re-
sults from several drug-eluting stent (DES) trials.
They suggest that the principal mechanism of edge restenosis in 
bare metal stent as in DES is through plaque shift and intimal hyper-
plasia proliferation beyond the stent edges, within the first millimeter 
from the stent.
Interestingly, the authors noted from several trials, including pacli-
taxel-, sirolimus-, zotarolimus-, and everolimus-eluting stents that de-
spite significant reduction in restenosis with DES compared with bare 
metal stent control, stent edge restenosis was nearly equally frequent in 
both DES and bare metal stent and could not be resolved at the proxi-
mal edge of the stents by drug elution from the stent.
The authors suggest that drug distribution downstream of the stent 
may produce a beneficial stent effect on the lumen distal from DES 
compared with bare metal stent. They propose this drug diffusion dis-
tal to the edge of the stent as a possible explanation of the difference 
between proximal and distal restenosis, which also might explain the 
relatively high restenosis rate at the proximal edge of DES observed 
in trials.
Based on our experience with optical coherence tomography,2,3 we 
strongly believe that another important phenomenon may explain the 
difference: incomplete stent apposition is a particularly frequent prob-
lem, and incomplete stent apposition assessed by intravascular ultra-
sound has been reported in up to one third of treated segments after 
DES implantation,4 affecting more frequently the proximal edge of the 
stent compared with the distal edge of the stent.2,4,5 Stents deployed 
across the origin of a side branch or covering long segments of tapering 
vessels (left anterior descending) are at particular risk, and postdilation 
with larger balloon is only effective if the balloon matches the proxi-
mal vessel diameter and is also covering the proximal edge. If the stent 
is incompletely expanded with its struts not in contact with the vessel 
wall, drug will diffuse from the coating within the bloodstream, in-
stead of diffusing to the intima and, therefore, prevent smooth muscle 
proliferation. Postprocedure malapposition may resolve by the rapid 
proliferation of neointimal tissue filling the gap between the stent strut 
and the vessel wall,6 which may thereby limit the risk of stent throm-
bosis but at the same time facilitate edge restenosis. If on the opposite, 
the stent struts are well apposed and embedded in the tissue (such as 
almost systematically observed at the distal edge of the stent), the drug 
can diffuse from the strut to the vessel and thereby prevent intimal 
hyperplasia.
The incidence of proximal edge incomplete stent apposition 
and its direct impact of edge restenosis should be assessed using 
high-resolution intravascular optical coherence tomography. Com-
parison of stent segment postimplantation and at follow-up may 
identify the respective propensity of partially deployed stent, its role 
on restenosis, and whether complete stent apposition at the proximal 
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